Publications


Books Published or In Press

Book Chapters Published or In Press

  • Church M, Casale TB: Principles of Pharmacotherapy. In: Allergy, 4th ed. Holgate ST, Church MK, Broide DH, Martinez FD (eds). Elsevier Saunders, pp147-169, 2012.
  • Lockey RF: Immunotherapy for Venom Allergy Comes of Age. In: Landmark Papers in Allergy. Sheikh A, Platts-Mills T, Worth A (eds). Oxford University Press, Oxford, UK, pp 159-161, 2013.
  • Lockey RF: Gastroesophageal Reflux Disease and Asthma. In: Global Atlas of Asthma. Akdis CA, Agache I (eds). European Academy of Allergy and Clinical Immunology (EAACI), Section B, Chapter 5, pp 95-99, 2013.
  • Glaum MC, Lockey RF: Allergen Specific Immunotherapy and Systemic Reactions. In: Anaphylaxis – Principles and Practice. Mamidipudi KT (ed). Nova Science Publishers, New York, 2013.
  • Dixit N, Glaum M, Kumar A, Cameron DF: Biological Systems for the Delivery of Nanoparticles. In: Nanomedicine in Drug Delivery. Kumar A, Mansour HM, Friedman A, Blough ER (eds). CRC Press/Taylor and Francis Group, 2013.
  • Casale TB: Severe Asthma. In: Global Atlas of Asthma. European Academy of Allergy and Clinical Immunology (EAACI). Akdis C, Agache J (eds), 2013.
  • Stokes J, Casale TB: Anti-IgE Therapy . In: Middleton’s Allergy: Principles and Practice, Eighth Edition. Adkinson NF, Jr, Bochner BS, Burks W, Busse WW, Holgate ST, Lemanske RF, Jr, O’Hehir RE (eds). Elsevier, Inc., 2013.
  • Pesek R, Lockey RF: Diagnosis and Management of Allergy to Hymenoptera (and other insects) Stings in Adolescents and Children. In: Clinical Decision Support: Pediatrics. McMillan JM, Barrett DJ, Boney CM, Jones MD (eds). Decision Support in Medicine, LLC. Wilmington, DE, 2013.
  • Fernández-Caldas E, Puerta L, Caraballo L, Lockey RF: Mite Allergens. In: Allergens and Allergen Immunotherapy: Subcutaneous, Sublingual and Oral, 5th ed. Lockey RF, Ledford DK (eds). CRC Press/Taylor & Francis Group, Boca Raton, FL, pp 181-201, 2014.
  • Müller U, Golden DBK, Lockey RF, Shin B: Immunotherapy for Hymenoptera Venom Hypersensitivity. In: Allergens and Allergen Immunotherapy: Subcutaneous, Sublingual and Oral, 5th ed. Lockey RF, Ledford DK (eds). CRC Press/Taylor & Francis Group, Boca Raton, FL, pp 401-15, 2014.
  • Bagg AS, Lockey RF: Adverse Effects and Fatalities Associated with Allergen Skin Testing and Subcutaneous Allergen Immunotherapy. In: Allergens and Allergen Immunotherapy: Subcutaneous, Sublingual and Oral, 5th ed. Lockey RF, Ledford DK (eds). CRC Press/Taylor & Francis Group, Boca Raton, FL, pp 447-59, 2014.
  • Cox L, Lockey RF: Instruction and Consent Forms for Subcutaneous Allergen Immunotherapy. In: Allergens and Allergen Immunotherapy: Subcutaneous, Sublingual and Oral, 5th ed. Lockey RF, Ledford DK (eds). CRC Press/Taylor & Francis Group, Boca Raton, FL, pp 497-512, 2014.
  • Fenny N, Dimov VV, Casale TB:. Recombinant and Modified Vaccines and Adjuvants Used for Allergen Immunotherapy. In: Allergens and Allergen Immunotherapy: Subcutaneous, Sublingual,and Oral, 5th ed. Lockey RF, Ledford DK (eds). CRC Press/Taylor & Francis Group, Boca Raton, FL, pp 419-426, 2014.
  • Rosenwasser LJ, Ledford DK: Antineutrophil Cytoplasmic Antibody – Positive Vasculitis – Comorbid and Coexisting. In: Asthma, Comorbidities, Co-Existing Conditions, and Differential Diagnoses. Lockey RF, Ledford DK (eds), in collaboration with the World Allergy Organization. Oxford University Press, New York, NY, pp 12 - 20, 2014.
  • Fox RW, Glaum MC: Vocal Cord Dysfunction and Paradoxical Vocal Fold Motion Disorder. In: Asthma, Comorbidities, Co-Existing Conditions, and Differential Diagnoses. Lockey RF, Ledford DK (eds), in collaboration with the World Allergy Organization. Oxford University Press, New York, NY, pp 288-296, 2014.
  • Pope C, deShazo D, King, MK: Asthma Over 65 – A Disease About Which Little is Known. In: Asthma, Comorbidities, Co-Existing Conditions, and Differential Diagnoses. Lockey RF, Ledford DK (eds), in collaboration with the World Allergy Organization. Oxford University Press, New York, NY, pp 441-52, 2014
  • Bellamkonda P, Casale TB: Management of Adult Asthma, In: Clinical Asthma: Theory and Practice. Bernstein J, Levy M (eds). CRC Press, 2014.

Scientific Articles Published or In Press

  • Lockey RF (Contributor): Writing Committee for the American Lung Association Asthma Clinical Research Centers: Lansoprazole for children with poorly controlled asthma. JAMA 2012; 307(4): 373-381.
  • Aljubran SA, Cox R, Parthasarathy PT, Ramanathan GK, Rajanbabu V, Bao H, Mohapatra SS, Lockey RF, Kolliputi N: Enhancer of Zeste Homolog 2 induces pulmonary artery smooth muscle cell proliferation. PLoS ONE 2012; 7(5):e37712.25.
  • Westermann-Clark E, Fitzhugh D, Lockey RF: Increasing cost of epinephrine autoinjectors. JACI 2012; 130(3): 822-823.
  • Jalali S, Ramanathan GK, Parthasarathy PT, Aljubran S, Galam L, Yunus A, Garcia S, Cox RR Jr, Lockey RF, Kolliputi N: Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation. PLoS ONE 2012; 7(10): e46808.
  • Elizalde A, Perez EE, Sriaroon P, Nguyen D, Lockey RF, Dorsey MJ: Intensive educational course in allergy and immunology. Allergy 2012; 67(9): 1085-6.
  • Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG, Canonica W, Carlsen KH, Cox L, Haahtela T, Lodrup Carlsen KC, Price D, Samolinski B, Simons FE, Wickman M, Annesi-Maesano I, Baena-Cagnani CE, Bergmann KC, Bindslev-Jensen C , Casale TB, et al: Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012;67(1):18-24.
  • Calderon MA, Cox L, Casale TB, Moingeon P, Demoly P: Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol 2012; 129(4):929-934.
  • Lewis E, Fernandez C, Nella K, Hopp R, Casale T, Gallagher C: Relationship of 25-hydroxyvitamin D and asthma control in children. Ann Allergy Asthma Immunol 2012;108(4):281-282.
  • Xie Y, Jiang H, Nguyen H, Jia S, Berro A, Panettieri RA, Wolff DW, Abel PW, Casale TB, Tu Y: Regulator of G-protein signaling 2 is a key modulator of airway hyperresponsiveness. J Allergy Clin Immunol 2012; 130(4): 968-976.
  • Jiang H, Xie Y, Abel PW, Toews ML, Townley RG, Casale TB, Tu Y: Targeting phosphoinositide 3-kinase y [gamma] in airway smooth muscle cells to suppress interleukin-13-induced mouse airway hyperresponsiveness. J Pharmacol Exp Ther 2012; 342(2): 305-311.
  • Brozek JL Kraft M, Krishnan, JA. Cloutier MM, Lazarus, SC. Li JT, Santesso N, Strunk, RC, CasaleTB: Long- acting beta agonist step-off in patients with controlled asthma – systematic review with meta-analysis. Arch Internal Med 2012; 27: 1-11.
  • Cox L, Casale TB, Nayak A, Bernstein D, Creticos P, Ambroisine L, Melac, M. Zeldin R: Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE. J Allergy Clin Immunol. 2012;130(6):1327-1334.e1.
  • Prasanna TP, Phillips O, Kolliputi. N: Thioredoxin catalysis and inflammasome regulation: directions for future research. J Biocatal Biotransformation 2012, 1:2.
  • Parthasarathy PT, Galam L, Huynh B, Yunus A, Abuelenen T, Castillo A, Kollongod RG, Cox R Jr, Kolliputi N: MicroRNA 16 modulates epithelial sodium channel in human alveolar epithelial cells. Biochem Biophys Res Commun 2012; 426(2): 203–208.
  • Cox RR Jr, Phillips O, Kolliputi N: Putting the brakes on acute lung injury: can resolvins suppress acute lung injury? Front Physiol 2012; 3:445.
  • Kolliputi N, Galam L, Parthasarathy PT, Tipparaju SM, Lockey RF: NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability. J Cell Physiol 2012; 227(9):3310-6.26.
  • Boyapalle S, Wong T, Garay J, Teng M, San Juan-Vergara H, Mohapatra S, Mohapatra S: Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS One 2012;7:e29386
  • Bakre A, Mitchell P, Coleman JK, Jones LP, Saavedra G, Teng M, Tompkins SM, Tripp RA: Respiratory syncytial virus (RSV) modifies microRNAs regulating host genes which affect virus replication. J Gen Virol 2012; 93:2346-56.
  • Wu W, Tran KC, Teng MN, Heesom KJ, Matthews DA, Barr JN, Hiscox JA: Solution of the human respiratory syncytial virus NS1 protein interactome highlights multiple effects on host cell biology. J Virol 2012: 86:7777-7789.
  • Hotard AL, Shaikh FY, Lee S, Yan D, Teng MN, Plemper RK, Crowe Jr. JE, Moore ML: A stabilized RNA virus reverse genetics system amenable to recombination mediated mutagenesis. Virology 2012; 434:129-36.
  • Lang JE, Mougey EB, Allayee H, Blake KV, Lockey R, Gong Y, Hossain J, Killen K, Lima JJ: Nemours Network for Asthma Research: Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods. Contemporary Clinical Trials 2013; 34(2): 326-35.
  • Riedl MA, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL: Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Annals of Allergy, Asthma and Immunology 2013; 110(4): 295-9.
  • Berstein JA, Fox,RW, Martin VT, Lockey RF: Headache and facial pain: differential diagnosis and treatment. J Allergy Clin Immunol: In Practice 2013; 1:242-51.
  • Demoly P, Calderon M, Casale TB, Scadding G, Annesi-Maesano I, Braun, J-J, Delaisi B, Haddad T, Malard O, Trébuchon F, Serrano E: Assessments of disease control in allergic rhinitis. Clin Translational Allergy 2013; 3(1):7.
  • Maurer M, Rosen K, Hsieh HJ, Saini S, Grattan C, Gimenez-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale TB: Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria. New Engl J Med 2013; 368(10):924-35.
  • Olsen J, DelasAlas HC, Casale TB: Aquagenic urticaria. J Allergy Clin Immunol:In Practice 2013; 1(3): 295-296.
  • Calderón MA, Casale TB, Cox L, Akdis AC, Burks AW, Nelson H, Jutel M, Demoly P: Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy 2013; 68(7):825-8.
  • Creticos P, Maloney J, Bernstein DI, Casale TB, Kaur A, Fisher R, Liu N, Murphy K, Nékám K, Nolte H: Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol. 2013; 131(5):1342-1349.
  • Vashisht P, Casale TB: Omalizumab for treatment of allergic rhinitis. Expert Opinion On Biological Therapy 2013; 13(6):933-945.
  • Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, Nelson H, Akdis CA: Update on allergy immunotherapy: American Academy of Allergy, Asthma and Immunology/European Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013;131(5):1288-1296.
  • Cruz C, Casale TB: Anaphylaxis to cat in a child with exclusive sensitivity to Fel d 1. J Allergy Clin Immunol In Practice 2013;1(4):416-417.
  • Cox L, Aaronson D, Casale TB, Honsinger R, Weber R: Allergy immunotherapy safety: location matters! J Allergy Clinical Immunology: In Practice 2013:1(5): 455-457.
  • Lane T, Flam B, Lockey R, Kolliputi N: TXNIP shuttling: missing link between oxidative stress and inflammasome activation. Front Physiol 2013;4:50.
  • Fukumoto J, Fukumoto I, Parthasarathy PT, Cox R, Huynh B, Ramanathan GK, Venugopal RB, Allen-Gipson DS, Lockey RF, Kolliputi N: NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am J Physiol Cell Physiol 2013; 305(2): C182-9.
  • Bandyopadhyay S, Lane T, Venugopal R, Parthasarathy PT, Cho Y, Galam L, Lockey R, Kolliputi N: MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2. Biochem Biophys Res Commun 2013; 439(3):407-12.
  • Qazi O, Parthasarathy PT, Lockey R, Kolliputi N: Can microRNAs keep inflammasomes in check? Front Genet 2013;4:30.
  • Panguluri SK, Tur J, Fukomoto J, Deng W, Sneed KB, Kolliputi N, Bennett ES, Tipparaju SM: Hyperoxia induced hypertrophy and ion channel remodeling in left ventricle. Am J Physiol Heart Circ Physiol 2013; 304(12): H1651-61.
  • Desai P, Tamarapu Parthasarathy P, Galam L, Lockey R, Kolliputi N: A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease. Front Physiol 2013; 4:156.
  • Fukumoto J, Kolliputi N: Human lung on a chip: innovative approach for understanding disease processes and effective drug testing. Front Pharmacol 2013; 3:205.
  • Grams D, Lockey R, Kolliputi N: Is isoprenylcysteine carboxyl methyltransferase the key to reverse ageing? Front Aging Neurosci 2013; 5:40.
  • Tian B, Zhao Y, Kalita M, Edeh CB, Paessler S, Casola A, Teng MN, Garofalo RP, Brasier AR: CDK9-dependent transcriptional elongation in the innate ISG response to RSV infection in airway epithelial cells. J Virol 2013; 87:7075-92.
  • Fuentes S, Crim RL, Beeler J, Teng MN, Golding H, Khurana S: Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization assay for respiratory syncytial virus. Vaccine 2013; 31:3987-94.
  • Kolliputi N, Lockey RF: Inflammasome inhibition suppresses alveolar cell permeability through retention of NRG-1. J Immunology, in press.
  • Sandhu MA, Dimov V, Romero FA, Wichman T, Casale TB: Effects of rosiglitazone on airway hyperresponsiveness and obstruction in asthma. Annals Allergy Asthma Immunol, in press.
  • Jonsson-Razdan P, Casale TB: Sublingual Immunotherapy (SLIT). Ann Resp Med, in press.

Review Articles/Editorials Published or In Press

  • Butt A, Rashid D, Lockey RF: Do hypoallergenic cats and dogs exist? Ann Allergy Asthma Immunol 2012;108(2): 74-76.
  • Ring J, Akdis C, Behrendt H, Lauener RP, Schappi G, Akdis M, Ammann W, Lockey RF, et al: Davos Declaration: Allergy as a global problem. Allergy 2012; 67: 141-143.
  • Calderon MA, Simons FER, Malling HJ, Lockey RF, Moingeon P, Demoly P: Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2012; 67: 302–311.
  • Lockey RF: History of the World Allergy Organization: Reflective recollections of the WAO Presidency, 2010 – 2011. WAO Journal 2012; 5(2): 28-35.
  • Lotvall J, Pawankar R, Wallace DC, Ajdus CA, Rosenwasser LJ, Weber RW, Wesley Burks A, Casale TB, et al: American Academy of Allergy, Asthma & Immunology (AAAA&I) The American College of Allergy, Asthma & Imunology (ACAAI), the European Academy of Allergy and Clinical Immunology, and the World Allergy Organization (WAO): We call for iCAALL: international collaboration for asthma, allergy and immunology. Ann Allergy Asthma Immunol 2012; 108(4):215-216; Allergy 2012; 67(4):449-450; JACI 2012; 129(4):904-5; World Allergy Org J 2012; 5(3):39-40.
  • Simons FER, Ardusso LRF, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, Ledford DK, Lockey RF, et al: 2012 Update: World Allergy Organization guidelines for the assessment and management of anaphylaxis. Current Opinion in Allergy & Clin Immunol 2012; 12(4): 389-99.
  • Lockey RF: The myth of hypoallergenic dogs (and cats). JACI 2012; 130(4):910-11.
  • Lockey RF (contributor), Sumino K, Holbrook JT, Wise RA, Rogers L: Asthma clinical trials of American Lung Association/Asthma Clinical Research Centers (ALA-ACRC): What have we learned in 12 years? Curr Respir Care Rep 2012; 1(4): 251-258.
  • Craig T, Pursun EA, Bork K, Bowen T, Boysen H, Farkas H, Grumach AS, Katelaris C, Lockey RF, et al: WAO guideline for the management of hereditary angioedema. WAO Journal 2012, 5:182-199.
  • Bousquet J, Schunemann HJ, Samolinski B, Lockey RF, et al: ARIA (Allergic rhinitis and its impact on asthma) – achievements in 10 years and future needs. JACI 2012; 130(5):1049-62.
  • Pawankar R, Canonica W, Holgate S, Lockey RF: Editorial: Allergic diseases and asthma: a major global health concern. Current Opinion in Allergy & Clinical Immunology 2012;12(1):39-41.
  • Ledford DK, Burks AW, Ballow M, Cox L, Wood RA, Casale TB. Statement regarding “The public health benefits of air pollution control”. J Allergy Clin Immunol 2012;130(1):24.
  • WHO collaborating Center for Asthma and Rhinitis, Bousquet J, Anto JM, Demoly P, Schunemann JH, Toaiga A, Casale TB, et al: Severe chronic allergy (and related) diseases: a uniform approach– a MedALL-GA(2)LEN –ARIA position paper. Int Arch Allergy Immunol 2012; 158(3):216-231.
  • Ballow M, Akdis CA, Casale TB, Wardlaw A, Wenzel S, Ballas Z, Lötvall J: Immune response modifiers in the treatment of asthma: A Practall document of the AAAAI and EAACI. J Allergy Clin Immunol 2012; 130(2):311-324.
  • Yorgancıoğlu A, Ozdemir C, Kalaycu O, Kalyocu AF, Bachert C, Baena-Cagnani CE, Casale TB, Chen YZ, Cruz AA, Demoly P, Fokkens WJ, Lodrup Carlsen KC, Mohammad Y, Mullol J, Ohta K, Papadopoulos NG, Pawankar R, Samolinski B, Schünemann HJ, Yusuf OM, Zuberbier T, Bousquet J: ARIA (Allergic rhinitis and its impact on asthma) Achievements in 10 years and future needs. Tuberk Toraks 2012; 60(1):92-7.
  • Busse WW, Ballas Z, Casale T, Cox L, Dimov V, Honsinger R, Jones C, Tracey J, Whalen K: Future of Allergy: Task Force Report. J Allergy Clin Immunol 2012; 130(4):1009-1010.
  • Papadopoulos NG, Arakawa H, Carlsen K.-H, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, Zar H, Akdis CA, Bacharier LB, Baraldi E, van Bever HP, de Blic J, Boner A, Burks W, Casale TB, Castro-Rodriguez JA, Chen YZ, El-Gamal YM, Everard ML, Frischer T, Geller M, Gereda J, Goh DY, Guilbert TW, Hedlin G, Heymann PW, Hong SJ, Hossny EM., Huang JL, Jackson DJ., de Jongste JC, Kalayci O, Aït-Khaled N, Kling S, Kuna P, Lau S, Ledford DK, Lee SI, Liu AH, Lockey RF, Lødrup-Carlsen K, Lötvall J, Morikawa A, Nieto A, Paramesh H, Pawankar R, Pohunek P, Pongracic J, Price D, Robertson C, Rosario N, Rossenwasser LJ, Sly PD, Stein R, Stick S, Szefler S, Taussig LM, Valovirta E, Vichyanond P, Wallace D, Weinberg E, Wennergren G, Wildhaber J, Zeiger RS: [ICON] Pediatric Asthma. Allergy 2012; 67(8): 976-997.
  • Simons FE, Ardusso LR, Bilò MB, Dimov V, Ebisawa M, El-Gamal YM, Ledford DK, Lockey RF, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY, Worm M; World Allergy Organization. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12(4):389-99.
  • Teng MN: The non-structural proteins of RSV: targeting interferon antagonists for vaccine development. Infectious Disorders-Drug Targets 2012; 12:129-37.
  • Ledford DK, Lockey RF: Asthma and Comorbidities. Current Opinion in Allergy and Clin Immunol 2013; 13(1): 78-86.
  • Pesek RD, Lockey RF: Management of insect sting hypersensitivity: an update. Allergy, Asthma & Immunology Research 2013; 5(3): 129.
  • Heinzerling L, Mari A, Bergmannn KC, Bresciani M, Burbach G, Darsow U, Durham S, Fokkens W, Gjomarkaj M, Haahtela T, Bom AT, Wohrl S, Maibach H, Lockey RF: The skin prick test. – European standards. Clinical and Translational Allergy 2013; 3:3.
  • WAO Task Force: Passalacqua G, Baena-Cagnani CE, Bousquet J, Canonica GW, Casale T, Cox L, Durham S, Larenas-Linnemann D, Ledford D, Pawankar R, Potter P, Rosario N, Wallace D, Lockey RF: Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. JACI 2013;132(1):93-8.
  • Talreja N, Lockey RF: Case of recurrent exophthalmos: angioedema versus idiopathic orbital pseudotumor. JACI: In Practice 2013; 1(5): 518-19.
  • Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF, Sanchez-Borges M, Genna GE, Sheikh A, Thong BY, Worm M: World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013; 162: 193-204.
  • Bernstein J, Fox RW, Martin VT, Lockey RF: Headache and facial pain: differential diagnosis and treatment. JACI: In Practice 2013; 1(3): 242-51.
  • Desai P, Parthasarathy PT, Galam L, Lockey RF, Kolliputi N: A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease. Frontiers in Physiology 2013; 4:156.
  • Lane T, Flam B, Lockey RF, Kollipputi N: TXNIP Shuttling: Missing link between oxidative stress and inflammasome activation. Frontiers in Oxidant Physiology 2013; 4:50.
  • Fukumoto J, Lockey R, Kolliputi N: New hope for Nutlin-3a therapy for pulmonary arterial hypertension. Frontiers in Pharmacology 2013; 4: 87.
  • Mehta J, Parthasarathy PT, Lockey RF, Kolliputi N: New Hope for a MicroRNA therapy for pulmonary arterial hypertension. Frontiers in Genetics 2013; 4: 137.
  • Grams D, Lockey RF, Kolliputi N: Is isoprenylcysteine carboxyl methyltransferase the key to reverse ageing? Frontiers in Aging Neuroscience 2013; 5:40.
  • Qazi O, Tamarapu P, Lockey RF, Kolliputi N: Can microRNAs keep inflammasomes in check? Front Physiol 2013; 4:30.
  • Stokes J, Casale TB: The relationship between IgE and allergic disease. Up To Date, in press.

Internet Publications